Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2005 Dec 17;331(7530):1474-5.
doi: 10.1136/bmj.331.7530.1474-c.

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: what does evidence from randomised trials show about celecoxib?

Jonathan L Underhill
Comment

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: what does evidence from randomised trials show about celecoxib?

Jonathan L Underhill. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Hippisley-Cox J, Coupland C, Logan R. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;331: 1310-6. (3 December.) - PMC - PubMed
    1. Silverstein FE, Faich G, Goldstein GL. Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284: 1247-55. - PubMed
    1. Jüni P, Rutjes AWS, Dieppe PA. Are selective COX 2 inhibitors superior to traditional non-steroidal anti-inflammatory drugs? BMJ 2002;324: 1287-8. - PMC - PubMed
    1. Lu HL. Statistical reviewer briefing document for the advisory committee. Available at: www.fda.gov/ohrms/dockets/ac/01/briefing/3677b1_04_stats.doc (accessed 8 Dec 2005.)
    1. Freemantle N. How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events? BMJ 2005;331: 836-8. (8 October.) - PMC - PubMed

MeSH terms